ERC-CG-2013-LS1
ERC-CG-2013-LS1
Programme: H2020
10 projects · €19,714,004 total EU contribution (project-level) · 11 participating organizations · 6 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€19,714,004
Countries active
Participant organizations by country (headquarters in CORDIS).
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Structural basis of mitochondrial inner membrane shape and dynamic MITOSHAPE · 616024 | FP7 | €1,999,972 | €1,999,972 | Details |
DNA Replication Stress in Cancer ReStreCa · 617102 | FP7 | €1,846,500 | €1,846,500 | Details |
The role of essential DNA metabolism genes in vertebrate chromosome replication DNAMEREP · 614541 | FP7 | €1,999,800 | €1,999,800 | Details |
TOR and Cellular Homeostasis TORCH · 614552 | FP7 | €1,991,686 | €1,991,686 | Details |
NMR Spectroscopy of very large complexes: the atomic details of the mRNA degradation machinery MRNA-DECAY · 616052 | FP7 | €1,966,800 | €1,966,800 | Details |
Specificity of translational control during unfolded protein response TRANSLATE · 617837 | FP7 | €1,999,435 | €1,999,435 | Details |
Regulation of DNA damage responses at the replication fork DDREGULATION · 616236 | FP7 | €1,996,356 | €1,996,356 | Details |
Developing novel therapies for systemic disorders by regulating Nitric Oxide (NO) substrates' availability NO-DISEASE · 614204 | FP7 | €1,915,555 | €1,915,555 | Details |
Regulation and function of linear ubiquitination by HOIP LUBI · 614711 | FP7 | €1,997,908 | €1,997,908 | Details |
Protein Translocation Through Bacterial Syringes BACTERIAL SYRINGES · 615984 | FP7 | €1,999,992 | €1,999,992 | Details |